EverHint – EMA 10 + Price + MACD – Top 12 Signals for Jul 23, 2026
What This Signal Is
Experimental strategy combining price crossing above EMA10 from below with MACD Line crossing above Signal Line from below. Both conditions must occur on the same day for a signal, providing double confirmation and higher-quality setups.
Entry Criteria:
- Buy: Price > EMA10 AND MACD line crosses above signal line
- Sell: Price < EMA10 AND MACD line crosses below signal line
- Minimum ADV: $40M (liquidity filter)
- Earnings buffer: 7 days pre/post earnings
- Fresh signal: All conditions met on today's close
Holding period: 1-3 weeks | Risk level: Medium-High
Market Context
Wednesday's session delivered a broad-based pullback across major indices, with the Nasdaq bearing the brunt of selling pressure at -2.15%, underscoring a rotation away from growth and momentum names. The S&P 500 and Dow Jones followed with more moderate declines, suggesting the weakness is concentrated in higher-multiple, technology-heavy segments rather than representing uniform market deterioration. This divergence is worth noting for EMA/MACD-based signals, as trending strategies tend to perform best in directional markets — a sharp single-day reversal can generate false crossovers and reduce signal reliability until price action stabilizes.
The VIX spike of +13.34%, pushing the fear gauge to 18.86, is the most critical data point for intraday traders today. While 18.86 remains below the threshold of acute stress (typically 25+), the magnitude of the single-day jump signals a meaningful shift in near-term risk appetite and implies wider intraday price swings. For EMA-10 and MACD signals, elevated volatility increases the probability of whipsaws, so position sizing and stop placement deserve extra attention. Signals that align with the broader trend direction will carry higher conviction than counter-trend setups in this environment.
The dominance of Industrials among today's top signals is an interesting counterpoint to the tech-led selloff, potentially reflecting sector rotation dynamics as capital moves from growth into more defensive or cyclically stable areas. Industrials tend to exhibit steadier trending behavior compared to high-beta growth sectors, which could actually improve the quality of EMA/MACD signal follow-through in that space. Traders should remain selective, favoring signals where price structure and momentum confirm one another, and treating any signals emerging from the most volatile sectors with additional caution given today's risk-off tone.
🟢 Buy Signals (12 of 12 total)
Ranked by RSI (lower RSI = more oversold for buy signals)
| # | Ticker | Company | Sector | Price | Insider | MCap |
|---|---|---|---|---|---|---|
| 1 | ARE | Alexandria Real Estate... | Real Estate | $50.12 | — | $8.7B |
| 2 | BEP | Brookfield Renewable P... | Utilities | $33.07 | — | $10.1B |
| 3 | EME | EMCOR Group, Inc. | Industrials | $769.07 | — | $34.2B |
| 4 | EQPT | EquipmentShare.com Inc. | Industrials | $19.40 | — | $4.9B |
| 5 | FCNCA | First Citizens BancSha... | Financial Services | $2212.77 | +$4,114 | $25.6B |
| 6 | FLS | Flowserve Corporation | Industrials | $71.66 | — | $9.2B |
| 7 | GGG | Graco Inc. | Industrials | $77.75 | +$99,857 | $12.9B |
| 8 | LHX | L3Harris Technologies,... | Industrials | $299.67 | -$119,032 | $55.8B |
| 9 | MEDP | Medpace Holdings, Inc. | Healthcare | $605.82 | — | $17.3B |
| 10 | NVCR | NovoCure Limited | Healthcare | $19.99 | — | $2.3B |
| 11 | SCI | Service Corporation In... | Consumer Cyclical | $79.34 | — | $10.9B |
| 12 | SLG | SL Green Realty Corp. | Real Estate | $53.61 | — | $3.8B |
Field Notes
Sector concentration: Industrials (5), Real Estate (2), Healthcare (2)
Insider selling: LHX (L3Harris Technologies, Inc., -$119,032)
Insider buying: FCNCA (First Citizens BancShares, Inc., +$4,114), GGG (Graco Inc., +$99,857)
Data coverage: 33.3% insider, 8.3% congressional, 0.0% earnings, 16.7% news
Peer Analysis
BEP (Brookfield Renewable Partners L.P.): Leads 5 peers: BEPC ($33.61), BIP ($41.04), AES ($14.83), OGE ($49.61), SMR ($8.80)
SCI (Service Corporation International): Leads 5 peers: SN ($145.83), CCK ($114.49), TXRH ($190.86), DECK ($96.23), HTHT ($40.62)
MEDP (Medpace Holdings, Inc.): Leads 5 peers: ILMN ($196.86), ICLR ($170.32), WAT ($382.41), CNC ($63.72), SNN ($29.77)
NVCR (NovoCure Limited): Leads 5 peers: AZTA ($28.30), KMTS ($21.57), STAA ($24.19), BLFS ($30.77), NEOG ($9.61)
Congressional Activity
BEP (Brookfield Renewable Partners L.P.) 🟢 Bullish
- 2 purchases by 1 member
Recent Headlines
MEDP (Medpace Holdings, Inc.)
- Medpace Soars After Q2 Beat, Strong Backlog Fuels Higher 2026 Outlook
- Medpace: 'Buy' On Financial Metric Improvements And Solid Q2 2026 Earnings
- Medpace Holdings, Inc. (MEDP) Q2 2026 Earnings Call Transcript
- Medpace Q2 Earnings Call Highlights
- Medpace (MEDP) Beats Q2 Earnings and Revenue Estimates
NVCR (NovoCure Limited)
- NovoCure Limited (NVCR) Q2 2026 Earnings Call Transcript
- NovoCure (NVCR) Reports Q2 Loss, Beats Revenue Estimates
- NovoCure Q2 Earnings Call Highlights
- Novocure Reports Second Quarter 2026 Financial Results
- Novocure Reports Second Quarter 2026 Financial Results
Vlad's Take
Today's signals: Strong sector concentration in Industrials (5 signals) suggests sector-specific rotation. 2 signals with insider buying adds conviction.
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/
📢 Support the project by liking, sharing, or subscribing — it helps more readers discover these signals.